Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived?

Journal of Clinical Psychopharmacology

Volumn 25, Issue 2, 2005, Pages 175-179

  Randall, Delia C ^a,b   Viswanath, Aparna ^a   Bharania, Punam ^a   Elsabagh, Sarah M ^a   Hartley, David E ^a   Shneerson, John M ^b   File, Sandra E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MODAFINIL; PLACEBO;

ADULT; ARTICLE; ATTENTION; BRAIN FUNCTION; CLINICAL TRIAL; COGNITION; COLOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPTH PERCEPTION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; FATIGUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LATENT PERIOD; LONG TERM MEMORY; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; MENTAL TASK; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; PATTERN RECOGNITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; RECALL; SELF CONCEPT; SLEEP DEPRIVATION; SOMNOLENCE; STATISTICAL SIGNIFICANCE; VERBAL MEMORY; VISUAL INFORMATION; VISUAL MEMORY; WORKING MEMORY;

ADULT; BENZHYDRYL COMPOUNDS; COGNITION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; REACTION TIME; SLEEP DEPRIVATION;

EID: 15444368645     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000155816.21467.25     Document Type: Article

References (12)

1. Dinges DF, Weaver TE. Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP. Sleep Med. 2003;4:393-402.
2. Buguet A, Moroz DE, Radomski MW. Modafinil - Medical considerations for use in sustained operations. Aviat Space Environ Med. 2003;74:659-663.
3. Hall SS. The quest for a smart pill. Sci Am. 2003;289:54-57, 60-65.
4. Turner DC, Robbins TW, Clark L, et al. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology. 2003;165:260-269.
5. Randall DC, Shneerson JM, Plaha KK, et al. Modafinil affects mood, but not cognitive function, in healthy young volunteers. Hum Psychopharmacol 2003;18:163-173.
6. Randall DC, Fleck NL, Shneerson JM, et al. The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers. Pharmacol Biochem Behav. 2004;77:547-555.
7. Moachon G, Kanmacher M, Clenet M, et al. Pharmacokinetic profile of modafinil. Drugs Today. 1996;32:23-33.
8. Hoddes E, Zarcone V, Smythe H, et al. Quantification of sleepiness: a new approach. Psychophysiology. 1973;10:431-436.
9. Kornetsky C, Vates TS, Kessler EK. A comparison of hypnotic and residual psychological effects of chlorpromazine and secobarbital in man. J Pharmacol Exp Ther. 1959;127:51-54.
10. Wechsler WD. Adult Intelligence Scale-Revised. New York: Psychological Corporation; 1981.
11. Curran HV, Schifano F, Lader M. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood. Psychopharmacology. 1991;103:83-90.
12. Gronwall DMA. Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills. 1977;44:367-373.